JAN 2 4 2004
510(K) Summary

Submitter: Cynosure, Inc.

10 Elizabeth Drive
Chelmsford, MA 01824

Contact: George Cho
Senior Vice President of Medical Technology

Date Summary Prepared: September 30, 2003

Device Trade Name: TriStar Aesthetic Workstation

Common Name: Medical Laser System

Classification Name: Instrument, surgical, powered, laser
79-GEX
21 CFR 878.48

Equivalent Device: VLS-Star and PhotoGenica YAG lasers

Device Description: The TriStar laser is a combination of two laser devices; one pulse dye
laser and the other Nd:YAG laser. They are housed in the same box

, with two separate laser energy delivery fibers.
Laser activation is by foot switch. Overall weight of the laser is 25 Kg,
and the size is 180x62x42 cm (HxWxD).
Electrical requirement is 110 VAC, 15A, 50-60 Hz, single phase.

Intended Use: The TriStar laser is indicated for treatment of vascular lesions,
pigmentated lesions, tattoos, wrinkles and hair removal.

Comparison: The TriStar laser is substantially equivalent to the predicated devices.
They have the same principle of operation, the same wavelength and
essentially the same power range as the predicate devices for the same
indications for uses.

Nonclinical Performance Data: none

Clinical Performance Data: none

Conclusion: The TriStar Aesthetic Workstation laser is another safe and effective
device for the intended applications.

Additional Information: none

Name of Manufacturer: Cynosure Inc.
Laser Model Name and Number: Tristar Aesthetic Workstation Laser
Laser Type: (Circle all that apply)
Alexandrite, Argon, CO2, Copper-Vapor, Digde, Dye) Nd:YAG>Erbium, Hol: YAG,
Krypton, Ruby, KTP/532, Excimer, HENE, Accessory, Other
Indications in this application:
At 1064nm the laser is indicated for a variety of uses including coagulation and hemostasis of
vascular lesions, treatment of wrinkles, long term hair removal. At 1320nm the laser is
indicated for use in general surgery and dermatology for coagulation and hemostasis of soft
tissue and for the treatment of fine lines and wrinkles. (Please see Indications for Use
Statement for more detailed list)
At 585-600 nm the laser is indicated for benign vascular and vascular dependent lesions
removal.
FDA Document Control Number: K033176
FDA Product Code: 79GEX
Reviewer Computer Initials: CYH
Date of Clearance Letter: 01/16/04
Basis of Approval: (Circle all that apply)
<Predicate Device (PD), Clinical Data (CD), Animal Data (AD), Specifications (SPECS),
Bench Tést Data (BTD), Historical Information (HI), Other
Description of Laser:
Operation Modes: (Circle all that apply)
CW. @ulsed) Q-Switched, Mode Locked, Contact, Free Beam, Other _
Wavelength in Nanometers: §85-600nm, 1064 nm, 1320nm
Power/Energy Range (Watts/Joules): max 60 J/cm?
Pulse Width: 0-40 ms :
Repitition Rate: 1-3 Hz
Delivery System: Fiber optic cables
Comments:

ee
f DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
a
"rn Food and Drug Administration
9200 Corporate Boulevard
JAN 2 2 2004 Rockville MD 20850
Mr. George Cho
Senior Vice President of Medical Technology
Cynosure, Inc.
10 Elizabeth Drive
Chelmsford, MA 01824-4145
Re: K033176
Trade/Device Name: TriStar Aesthetic Workstation Laser
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and plastic surgery and
dermatology
Regulatory Class: II
Product Code: GEX
Dated: September 30, 2004
Received: December 29, 2004
Dear Mr. Cho:
We have reviewed your Section 510(k) premarket notification of intent (o market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug.
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the gencral controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class I] (Special Controls) or class I] (PMA). it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Picase be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labcling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820), and if applicable. the elegtronic
product radiation control provisions (Sections 531-542 of the Act): 21 CPR 1000-1050.

Page 2 — Mr. George Cho
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801). please
contact the Office of Compliance at (301) 594-4659, Also. please note the regulation entitled.
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www. fda.gov/cdrh/dsma/dsmamain html

Sincerely yours,

for Mowe, ( ee

Celia M. Witten, Ph.D.. M.D.

Director

Division of General, Restorative

and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health

Enclosure

510(k) Number (if known): KO” , > | \
Device Name: TriStar Aesthetic Workstation Laser
Indications For Use:
585nm — 600nm: The TriStar Aesthetic Workstation laser is indicated for benign vascular and vascular
dependent lesions removal. :
1064nm: The TriStar laser is intended for the coagulation and hemostasis of benign vascular leasions
such as, but not limited to, port wine stains, hemangiomas, warts, telangiectasia, rosacea, venus laske, leg
veins, spider veins and poikiloderma of civatte and treatment of benign cutaneous lesions such as but not
limited to, lentigos (age spots), solar lentigos (sun spots), café au lait macules, seborrheic keratoses, nevi,
chloasma, verrucea, skin tags, keratoses, tattoos (significant reduction in the intensity of black and/or
blue/black tattoos) and plaques. ‘
The laser is also indicated for th4 treatment of wrinkles such as, but not limited to, periocular and perioral
wrinkles.
Additionally, the laser is indicated for the removal of unwanted hair, for the stable long tern, or
permanent, hair reduction through selective targeting of melanin in hair follicles, and for the treatment of
psuedofolliculitis barbae (PFB).
1320 nm: The TriStar laser is indicated for use in gental surgery and dermatology for the incision,
excision, ablation, vaporization, coagulation and hemostasis of soft tissue. It is also indicated for the
treatment of periorbital and perioral wrinkles. It is also indicated for the treatment of fine lines and
wrinkles.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
re ~~ Concurrence of CDRH, Office of Device Evaluation (ODE) ne
1 ye
Naan 0. Vrovod
sion Sig Oe}
rowsion oF Ger. 1, Restorative
onu Neurologic! Govices
Prescription Use v OR Over-The-Counter Use___
(Optional Format 1-2-96)

